Evaluation and comparison of plasma level of brain-derived neurotrophic factor before and after treatment with methylphenidate in children and adolescent with ADHD.
The aim of this study is comparison of plasma level of brain-derived neurotrophic factor before and after treatment with methylphenidate in children and adolescent with ADHD. This is a before-after study without placebo. Samples consist of 30 children and adolescents suffering from ADHD who referring to the SHAFA hospital in Rasht. Sampling is based on DSM-IV oriented clinical interview and hemi-structured inventory of K-SADS. Inclusion criteria: age below 18, absence of any other axis I diagnosis, absence of any neurological disorder and use of psychotropic drug within the last month, IQ>70. Exclusion criteria: drug discontinue due to side effects, augmentation of any other psychotropic medication, occurring of any major neurological and psychiatric disorder, acute and febrile disease within current 2weeks. Plasma level of BDNF will be measured according to the kit instructions. After 4 weeks dose adjustment, patients will undergo treatment with methylphenidate more 6 weeks. Ultimately symptom severity and plasma Level of BDNF will be measured again.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT201108067237N1
Registration date:2011-08-10, 1390/05/19
Registration timing:prospective
Last update:
Update count:0
Registration date
2011-08-10, 1390/05/19
Registrant information
Name
Maryam Kousha
Name of organization / entity
Guilan University of Medical Science
Country
Iran (Islamic Republic of)
Phone
+98 13 1666 1163
Email address
m-kousha@gums.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice chancellor for Research- Guilan University of Medical Sciences- Iran
Expected recruitment start date
2011-09-23, 1390/07/01
Expected recruitment end date
2012-09-22, 1391/07/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation and comparison of plasma level of brain-derived neurotrophic factor before and after treatment with methylphenidate in children and adolescent with ADHD.
Public title
Evaluation of methylphenidate effect on brain growth factor.
Purpose
Basic scienece
Inclusion/Exclusion criteria
Inclusion criteria: age below 18; absence of any other axis I diagnosis; absence of any neurological disorder; use of psychothropic drug within the last month; IQ>70.
Exclusion criteria: drug discontinue due to side effects(tics, hallucinations, depressed mood, OCD, ...); augmentation of any other psychotropic medication; occuring of any major neurological and psychiatric disorder (eg, depression, bipolare, psychotic disorders); acute and febral disease within current 2weeks.